Find an Edison® System Histotripsy Provider

AdventHealth Altamonte Springs

AdventHealth Cancer Institute
Radiation Oncology and Interventional Radiology
Altamonte Springs, FL

AdventHealth Celebration

AdventHealth Cancer Institute
Surgical Oncology
Celebration, FL

Cleveland Clinic

Department of Hepatobiliary Surgery
Cleveland, OH

Johns Hopkins Hospital

Department of Radiology
Baltimore, MD

Mayo Clinic

Department of Radiology
Rochester, MN

New York University

Division of Hepatobiliary and Pancreatic Surgery
New York City, NY

Northeast Georgia Medical Center

Hepato-Pancreato-Biliary Surgery & Complex Surgical Oncology
Gainesville, GA

NYP-Weill Cornell Medical Center

Interventional Radiology
Liver/Transplant Surgery
New York City, NY

Presbyterian St. Lukes Medical Center

Denver, CO

Providence Mission Hospital

Leonard Cancer Institute
Interventional Radiology
Mission Viejo, CA

Providence-Swedish Medical Center

Swedish Cancer Institute
Swedish Surgical Specialists
Seattle, WA

Renown Regional Medical Center

Division of Surgical Oncology

Dr. Christos Galanopoulos

Dr. Randy Zuckerman

Dr. Nick Manguso Reno, NV

RUSH University

Department of Interventional Radiology
Chicago, IL

Tawam Hospital

Al-Ain, United Arab Emirates
+971 0545838790

UChicago Medicine

Department of Interventional Radiology
Chicago, IL

University of Michigan

Department of Radiology
Ann Arbor, MI

University of Rochester Medical Center

Department of Surgery
Rochester, NY

University of Wisconsin

Department of Radiology
Madison, Wisconsin

Global Partners and Providers

Gulf MEdical (KSA / Bahrain)

Contact: Eng. Mohamed A. Raouf
Director of New Technologies
Advanced Surgical Technologies
Mobile: +966-56-6053333
Email: and

Naghi Medical (United Arab Emirates)

Contact: Eng. Tamer Alsmadi
Business Unit Manager
Advanced Surgical Technologies
Email: and

Last updated on June 25, 2024

Caution: Federal law (USA) restricts this device to sale by or on the order of a physician.

The Edison® System is intended for the non-invasive mechanical destruction of liver tumors, including the partial or complete destruction of unresectable liver tumors via histotripsy. The FDA has not evaluated the Edison System for the treatment of any disease including, but not limited to, cancer or evaluated any specific cancer outcomes (such as local tumor progression, 5-year survival or overall survival). The System should only be used by persons who have completed training performed by HistoSonics, and its use guided by the clinical judgment of an appropriately trained physician. Refer to the device Instructions for Use for a complete list of warnings, precautions and a summary of clinical trial results, including reported adverse events.

Footer last updated on November 8, 2023
X New Twitter Logo
© 2019-2023 HistoSonics®. All rights reserved.